FDA Approved: BUDESONIDE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved the original application for Budesonide from Actavis Pharma, Inc. (ANDA205457).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Chronic Obstructive Pulmonary Disease
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

ORIG AP for BUDESONIDE (BUDESONIDE)